Opinion|Videos|October 17, 2024

Impact of IPF on Quality of Life and Financial Considerations

Toby Maher, MD, PhD, discusses how idiopathic pulmonary fibrosis (IPF) severely affects patients’ quality of life and daily functioning, with a median survival that underscores the disease’s severity, while also highlighting the substantial financial burden and health care resource utilization associated with managing this condition.

Video content above is prompted by the following:

  1. How does IPF impact a patient’s quality of life and ability to perform activities of daily living? What is the median survival for patients with IPF? 
  2. Can you describe the financial impact and health care resource utilization for patients with IPF?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo